These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 2501714)

  • 41. Oral iron absorption test should not be performed with iron drops containing ferric iron.
    Andersen SL; Gyrup C; Handberg A; Nielsen GL
    Dan Med J; 2015 Aug; 62(8):A5116. PubMed ID: 26239588
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Analysis of glycosaminoglycans in human serum after oral administration of chondroitin sulfate.
    Baici A; Hörler D; Moser B; Hofer HO; Fehr K; Wagenhäuser FJ
    Rheumatol Int; 1992; 12(3):81-8. PubMed ID: 1411092
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Poly-ion Complex of Chondroitin Sulfate and Spermine and Its Effect on Oral Chondroitin Sulfate Bioavailability.
    Ge D; Higashi K; Ito D; Nagano K; Ishikawa R; Terui Y; Higashi K; Moribe K; Linhardt RJ; Toida T
    Chem Pharm Bull (Tokyo); 2016; 64(5):390-8. PubMed ID: 27150471
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Bovine ferritin iron bioavailability in man.
    Skikne B; Fonzo D; Lynch SR; Cook JD
    Eur J Clin Invest; 1997 Mar; 27(3):228-33. PubMed ID: 9088859
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Absorbability and therapeutic effectiveness of tri-valent iron contained in iron-(III)-citrate and iron-(III)-hydroxide-carbohydrate complexes].
    Heinrich HC
    Med Welt; 1978 Mar; 29(13):532-7. PubMed ID: 634112
    [No Abstract]   [Full Text] [Related]  

  • 46. Quantification of orally administered chondroitin sulfate oligosaccharides in human plasma and urine.
    Mizuta H; Kawahara S; Tsutsumi N; Miyamoto N
    Glycobiology; 2023 Oct; 33(9):755-763. PubMed ID: 37440435
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Oral absorption and clearance of partially depolymerized fucosyl chondroitin sulfate from sea cucumber.
    Imanari T; Washio Y; Huang Y; Toyoda H; Suzuki A; Toida T
    Thromb Res; 1999 Feb; 93(3):129-35. PubMed ID: 10030829
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Iron (FeSo4) bioavailability in obese subjects submitted to bariatric surgery.
    Bueno L; Pizzo JC; Marchini JS; Dutra-de-Oliveira JE; Dos Santos JE; Barbosa Junior F
    Nutr Hosp; 2013; 28(1):100-4. PubMed ID: 23808436
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Chondroitin sulfate and its nanocomposites with protamine or chitosan stabilize and deliver available nanosized iron.
    Feng G; Tang S; Gang Y; Zeng M; Wu H
    Int J Biol Macromol; 2020 May; 150():501-508. PubMed ID: 32061694
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Zinc tolerance test in uremia. Effect of ferrous sulfate and aluminum hydroxide.
    Abu-Hamdan DK; Mahajan SK; Migdal SD; Prasad AS; McDonald FD
    Ann Intern Med; 1986 Jan; 104(1):50-2. PubMed ID: 3940504
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Bio-availability of oral iron preparations (author's transl)].
    Dietzfelbinger H; Kaboth W
    Dtsch Med Wochenschr; 1979 May; 104(20):742-6. PubMed ID: 446286
    [No Abstract]   [Full Text] [Related]  

  • 52. [Experimental contribution to the absorption of orally administered iron].
    Führ J
    Med Welt; 1979 Sep; 30(38):1410-2. PubMed ID: 481193
    [No Abstract]   [Full Text] [Related]  

  • 53. Bioavailability of the iron formulated as natural ferric protein (TM/FMOA) and natural ferric protein + folic acid (TM/FMOA+FOL).
    González-Peñas E; Martinez P; Gimeno M; Coronel P
    Eur J Drug Metab Pharmacokinet; 1998; 23(2):213-7. PubMed ID: 9725484
    [TBL] [Abstract][Full Text] [Related]  

  • 54. About oral absorption and human pharmacokinetics of chondroitin sulfate.
    Volpi N
    Osteoarthritis Cartilage; 2010 Aug; 18(8):1104-5; author reply 1106-7. PubMed ID: 20510382
    [No Abstract]   [Full Text] [Related]  

  • 55. Effect of twice-daily oral administration of a chondroitin sulfate-containing supplement on urine chondroitin sulfate concentrations in dogs.
    Wood MW; Barrett-Wilt GA
    Am J Vet Res; 2019 Aug; 80(8):799-805. PubMed ID: 31339761
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Clinical applications of ion-sensor].
    Sekiguchi M
    Rinsho Byori; 1992 May; 40(5):479-82. PubMed ID: 1354759
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [The bioavailability of Ce-Ferro forte].
    Heinrich HC; Gabbe EE
    Med Klin; 1979 Aug; 74(32-33):1196-8. PubMed ID: 470799
    [No Abstract]   [Full Text] [Related]  

  • 58. Reference values for oral iron absorption of bivalent iron in healthy volunteers.
    Kloepfer K; Schmid P; Wuillemin WA; Rüfer A
    Swiss Med Wkly; 2015; 145():w14063. PubMed ID: 25612208
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Absorption of magnesium from orally administered magnesium sulfate in man.
    Morris ME; LeRoy S; Sutton SC
    J Toxicol Clin Toxicol; 1987; 25(5):371-82. PubMed ID: 3430654
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Effect of chondroitin sulfates on atherosclerosis. I. Long term oral administration of chondroitin sulfates to atherosclerotic subjects].
    Nakazawa K
    Nihon Naika Gakkai Zasshi; 1970 Oct; 59(10):1084-92. PubMed ID: 4920422
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.